TM editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.
Company: Samsung Biologics Company Limited
Bloomberg ticker: 207940 KS
Market cap: US$33,975m
Background: Samsung Biologics Company Limited is a contract manufacturer and developer of biopharmaceutical products. A biopharmaceutical is a drug made from biological sources. The company has global leading pharmaceutical companies as its clients.
World Class Benchmarking of Samsung Biologics
(Click on image to enlarge)
- Profitable Growth rank of 5 was up compared to the prior period’s 6th rank
- This is average performance compared to 420 medium Health Care companies worldwide
- Profitability rank of 6 was worse than its Growth rank of 3
- Profitability rank of 6 was up compared to the prior period’s 7th rank
- This is below average performance compared to peers
- Growth rank of 3 was down compared to the prior period’s 1st rank
- This is above average performance compared to peers
Comments
Log in or sign up to join the conversation.